Trulicity is one of several GLP-1 receptor agonist diabetes medications prescribed to treat type 2 diabetes and, in some cases, discussed alongside drugs marketed as a weight loss drug
F0 adults were synchronized by hypochlorite treatment after 24 h, then transferred to NGMi RNAi plates to generate F1 offspring
In a phase II trial, adults with a BMI of 30 or 27 kg/m with comorbidities were randomized to receive efpeglenatide at doses of 4 mg weekly, 6 mg weekly, 6 mg biweekly, or 8 mg biweekly, or a placebo, all combined with a hypocaloric diet [17]
Figures 13 were modified from Servier Medical Art ( licensed under a Creative Common Attribution 4.0 Generic License
Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs